BlackRock, Inc. 13D and 13G filings for Checkpoint Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-05-07 5:09 pm Purchase |
2021-04-30 | 13G | Checkpoint Therapeutics, Inc. CKPT |
BlackRock Inc. BLK |
348,761 4.800% |
24,702 (+7.62%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT |
BlackRock Inc. BLK |
324,060 5.300% |
179,974 (+124.91%) |
Filing |